Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes

• Published in: Cardiovascular diabetology Vol. 19; no. 1; pp. 1 - 75
• Main Authors: Katakami, Naoto, Omori, Kazuo, Taya, Naohiro, Arakawa, Shoya, Takahara, Mitsuyoshi, Matsuoka, Taka-aki, Tsugawa, Hiroshi, Furuno, Masahiro, Bamba, Takeshi, Fukusaki, Eiichiro, Shimomura, Iichiro
• Format: Journal Article
• Language: English
• Published: London BioMed Central 11-06-2020; BMC
• Subjects: Age; Ankle; Arterial stiffness; Atherosclerosis; Blood pressure; Body mass index; Brachial ankle pulse wave velocity (PWV); Cardiovascular disease; Creatinine; Datasets; Diabetes; Diabetes mellitus (non-insulin dependent); Gas chromatography; Homeostasis; Hospitals; Hypertension; Kinases; Mannitol; Mass spectroscopy; Metabolism; Metabolites; Metabolomics; Obesity; Original Investigation; Patients; Plasma; Plasma levels; Pyroglutamic acid; Regression analysis; Risk factors; Software; Standard deviation; Statistical analysis; Studies; Sulfates; Japan
• ISSN: 1475-2840; 1475-2840
• DOI: 10.1186/s12933-020-01057-w

Background Although an increased arterial stiffness has been associated with traditional coronary risk factors, the risk factors and pathology of arterial stiffness remain unclear. In this study, we aimed to identify the plasma metabolites associated with arterial stiffness in patients with type 2 diabetes mellitus. Methods We used the metabolomic data of 209 patients with type 2 diabetes as the first dataset for screening. To form the second dataset for validation, we enlisted an additional 31 individuals with type 2 diabetes. The non-targeted metabolome analysis of fasting plasma samples using gas chromatography coupled with mass spectrometry and the measurement of brachial-ankle pulse wave velocity (baPWV) were performed. Results A total of 65 annotated metabolites were detected. In the screening dataset, there were statistically significant associations between the baPWV and plasma levels of indoxyl sulfate (r = 0.226, p = 0.001), mannitol (r = 0.178, p = 0.010), mesoerythritol (r = 0.234, p = 0.001), and pyroglutamic acid (r = 0.182, p = 0.008). Multivariate regression analyses revealed that the plasma levels of mesoerythritol were significantly (β = 0.163, p = 0.025) and that of indoxyl sulfate were marginally (β = 0.124, p = 0.076) associated with baPWV, even after adjusting for traditional coronary risk factors. In the independent validation dataset, there was a statistically significant association between the baPWV and plasma levels of indoxyl sulfate (r = 0.430, p = 0.016). However, significant associations between the baPWV and plasma levels of the other three metabolites were not confirmed. Conclusions/interpretation The plasma levels of indoxyl sulfate were associated with arterial stiffness in Japanese patients with type 2 diabetes. Although the plasma levels of mannitol, mesoerythritol, and pyroglutamic acid were also associated with arterial stiffness, further investigation is needed to verify the results.